ArticleAnnals of hematology2023

Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia-a real-world analysis of the Polish Adult Leukemia Study Group.

Anita Soboń et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.